Innovative Sleep Therapy Shows Promise for Cancer Patients and Their Caregivers

Can Innovative Dyadic Interventions Enhance Sleep Health in Cancer Care?

The field of cancer supportive care is witnessing an innovative approach to addressing sleep disturbances with the development of a dyadic intervention targeting both cancer patients and their sleep-partner caregivers. The recently registered clinical trial (NCT06571305) at the University of Miami introduces the Brief Behavioral Treatment for Insomnia for Couples with Cancer (BBTI-CC), representing a significant advancement in addressing the interconnected sleep health needs of those affected by cancer.

Sleep disturbance represents a pervasive concern among cancer survivors, with prevalence rates ranging from 65% to 95%, substantially higher than the 14%-35% observed in age-matched individuals without cancer and the general population. These disturbances significantly impact quality of life, disease progression, and overall survival in cancer patients. Similarly, family caregivers of cancer patients experience disproportionately high rates of sleep problems (63%-90%), exceeding those reported by caregivers for other chronic conditions. The development of BBTI-CC acknowledges the reality that approximately 70% of adults share a bed with a significant other, creating a shared sleep environment where one partner's sleep patterns inevitably affect the other's sleep quality.

While Cognitive Behavioral Therapy for Insomnia (CBT-I) remains the gold standard for treating sleep disturbances, its widespread implementation faces significant barriers, including the shortage of trained clinicians, extensive treatment duration (6-10 hours over 6-20 weeks), and its primary focus on patients with primary insomnia rather than those with medical comorbidities. Brief Behavioral Treatment for Insomnia (BBTI) emerged as a more accessible alternative, delivered over just 2-4 weekly sessions by clinicians familiar with health promotion but not necessarily trained in CBT. The BBTI-CC protocol adapts this approach specifically for the cancer context, with important modifications to accommodate cancer-related fatigue and treatment effects while addressing the dyadic nature of sleep.

What Does the Feasibility Study Reveal About Methodology and Endpoints?

The single-arm feasibility study will enroll 18 patient-caregiver dyads (36 participants) from Brevard County, Florida, using a combination of direct clinician referrals and identification through the Sylvester Comprehensive Cancer Center Tumor Registry. Eligibility criteria include patients with stage I-IV solid tumors diagnosed within the past three years who share a bed with their caregiver at least four nights weekly. Both patients and caregivers must demonstrate at least mild-to-moderate sleep disturbance (Pittsburgh Sleep Quality Index score ≥5) and be willing to modify suboptimal sleep habits. The protocol thoughtfully excludes individuals with untreated psychosis, major depressive disorder, bipolar disorder, substance dependencies, or active suicidal attempts within the past year, as well as those with untreated sleep disorders that would require different interventions.

The intervention consists of four weekly hour-long sessions delivered via HIPAA-compliant video platform to both patient and caregiver simultaneously. Session content progresses logically through sleep hygiene education (Session 1), stimulus control and sleep compression principles (Session 2), troubleshooting adherence barriers (Session 3), and relapse prevention strategies (Session 4). A crucial adaptation from standard BBTI is the relaxation of sleep restriction guidelines to ensure prescribed time in bed is not less than 7 hours, even if actual sleep time is less than 6.5 hours, acknowledging the sleepiness or drowsiness that often accompanies cancer treatment. The intervention is further tailored using 7-day sleep logs completed before the first session, allowing the interventionist to customize recommendations based on each participant's unique sleep patterns and challenges.

The study will assess feasibility through enrollment and retention rates, with success defined as achieving ≥75% enrollment of eligible dyads and ≥80% completion rate without adverse events. Acceptability will be measured through participant satisfaction ratings across eight domains, with a threshold of ≥80% satisfaction (≥4 out of 5 on rating scales). Preliminary efficacy will be evaluated through changes in sleep efficiency (primary outcome) calculated from daily sleep logs, as well as secondary measures including global sleep disturbance, subjective sleep quality, and insomnia severity. The study is powered to detect a large effect (d=0.8) with 80% power and a two-tailed alpha of 0.05, requiring at least 15 dyads to complete the protocol.

How Could This Approach Address Critical Gaps in Cancer Sleep Care?

This innovative approach addresses several critical gaps in current sleep interventions for cancer patients and caregivers. First, it recognizes sleep as a shared health behavior influenced by relationship dynamics and partner behaviors. Second, it acknowledges the unique challenges of cancer treatment on sleep patterns, incorporating flexibility in behavioral recommendations rather than applying rigid protocols developed for primary insomnia. Third, it emphasizes accessibility by utilizing a brief intervention format delivered by providers who need not be CBT specialists, potentially expanding the availability of effective sleep treatment for this vulnerable population.

The results of this feasibility study will inform subsequent refinements to the BBTI-CC protocol before advancing to randomized controlled trials. The investigators acknowledge several challenges in implementing this protocol, including the heterogeneity of cancer types and treatments represented in the sample, the need to address age-related comorbidities that frequently accompany cancer, and the logistics of scheduling sessions to accommodate participants' existing social and employment roles. These practical considerations highlight the complexity of delivering behavioral interventions in real-world settings while maintaining scientific rigor.

Will Dyadic Interventions Shift Paradigms in Symptom Management?

Could this dyadic approach to sleep disturbance represent a paradigm shift in how we conceptualize and treat symptoms in cancer care? As healthcare increasingly recognizes the interconnectedness of patient and caregiver wellbeing, interventions targeting shared health behaviors may become more prominent. What other symptom management approaches might benefit from similar dyadic frameworks? The BBTI-CC trial represents an important step toward understanding how behavioral interventions can be optimally tailored to address the complex, interconnected needs of those affected by cancer.

What remains to be seen is whether the modified BBTI approach will demonstrate sufficient efficacy across diverse cancer types and treatment regimens, and whether the dyadic format enhances outcomes compared to individually-delivered interventions. As the field of psycho-oncology continues to evolve, the integration of relationship dynamics into symptom management represents a promising frontier that acknowledges the profound impact of cancer on the entire family system rather than the patient in isolation.

What Are the Next Steps and Clinical Implications?

The study timeline indicates that participant recruitment and data collection began in August 2024 and are estimated to complete by June 2025. Following the study's completion, results will be published according to agreements with the funding agency and institutional guidelines, with data being made available on Open Science Forum upon publication acceptance. This transparency in data sharing will allow other researchers to build upon these findings and potentially extend this dyadic approach to other populations affected by cancer-related sleep disturbances.

How might clinicians further tailor behavioral sleep interventions to accommodate the diverse symptom profiles associated with different cancer treatments? What considerations should be made when implementing dyadic interventions in clinical settings where traditional patient-centered approaches predominate? These questions highlight the potential for BBTI-CC to not only address an immediate clinical need but also to stimulate broader conversations about the role of interpersonal dynamics in symptom management throughout the cancer care continuum.

Summary

The University of Miami is conducting a clinical trial testing the Brief Behavioral Treatment for Insomnia for Couples with Cancer (BBTI-CC), a novel intervention addressing sleep disturbances in both cancer patients and their caregivers. The study involves 18 patient-caregiver dyads participating in four weekly hour-long virtual sessions. The treatment adapts traditional insomnia protocols to accommodate cancer-related challenges while acknowledging the shared nature of sleep between partners. The intervention's success will be measured through enrollment rates, participant satisfaction, and improvements in sleep efficiency. This approach represents a potential paradigm shift in cancer symptom management by recognizing the interconnected health needs of patients and caregivers, with implications for future treatment protocols across various cancer types.